title: N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphan.
authors.forename: J L
authors.initials: JL
authors.lastname: Montastruc
authors.forename: N
authors.initials: N
authors.lastname: Fabre
authors.forename: O
authors.initials: O
authors.lastname: Rascol
authors.forename: J M
authors.initials: JM
authors.lastname: Senard
authors.forename: O
authors.initials: O
authors.lastname: Blin
mesh_terms: D000368:Aged; D003915:Dextromethorphan / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors* / Q000502:physiology; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000502:physiology
chemical_list: D016194:Receptors, N-Methyl-D-Aspartate; D007980:Levodopa; D016202:N-Methylaspartate; D003915:Dextromethorphan